VWAV earnings analysis
What we found in VWAV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q text does not include the financial statements or MD&A, so revenue, margins, EPS, segment results, balance-sheet trends and cash-flow metrics cannot be assessed. The filing is negative on financial controls and liquidity: disclosure controls were deemed ineffective as of June 30, 2026, cash was approximately $14 million, and management identifies substantial operating losses and going-concern risk absent committed support. Liquidity is further pressured by the $20 million YA II loan and its $2.5 million monthly amortization requirement, alongside substantial dilution and unresolved litigation exposure.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Approximately $14 million of cash
- The company reported approximately $14 million of cash as of June 30, 2026, which management identified as its principal source of liquidity.
- Up to $50 million SEPA capacity
- VisionWave has access to a SEPA allowing it to sell up to $50 million of common stock, subject to registration, market, ownership and exchange-cap conditions.
- July notes fully repaid
- The company repaid $396,704 on the July 2025 Notes, including $42,504 of interest; the balance of those notes was $0 at June 30, 2026.
- Multiple strategic transactions completed
- During the quarter, the company issued 3,500,000 shares for the xClibre asset acquisition, 945,251 shares to SaverOne, 386,386 shares to management, 475,590 shares to T3 Defense and 55,000 shares to a vendor.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Disclosure controls deemed ineffective
- Management concluded that disclosure controls and procedures were not effective as of June 30, 2026. The filing also states that no changes during the quarter materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
- Limited liquidity and going-concern risk
- Management states that, absent mitigating plans and committed support, the company’s liquidity and cash runway would raise substantial doubt about its ability to continue as a going concern within one year. Cash was approximately $14 million at June 30, 2026, while the company expects substantial operating losses to continue.
- Material YA II debt obligations
- The February 2026 YA II senior loan has $20 million of principal, requires monthly amortization of $2.5 million plus a 2% premium, and carries 18% default interest. An uncured event of default could accelerate repayment.
- Unresolved Maxim litigation
- Maxim Group alleges approximately $1.33 million of unpaid placement fees, while VisionWave separately seeks repayment of approximately $210,000 and rescission of an approximately $1.4 million invoice. The company states that the ultimate outcome and potential loss cannot currently be estimated.
- Substantial equity dilution risk
- The S-1 registers resale of approximately 6,148,943 shares, including warrant shares, and the company also issued 5,362,227 shares during the quarter across the disclosed xClibre, SaverOne, T3 Defense and vendor transactions, creating substantial dilution risk.
- Transaction and valuation uncertainty
- The company states that there were no material changes to risk factors previously disclosed in the September 30, 2025 Form 10-K. Supplemental risks nevertheless highlight the $40 million common-stock consideration contemplated for the proposed data-center joint venture and the $1.0 billion internal reference value used for that JV without an independent valuation or fairness opinion.
What they said about what is next.
No quantitative revenue or EPS guidance was provided in the filing; the 10-Q does not include an operating outlook. Management states that capital expenditures are expected to remain significant, but provides no amount.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 20, 2026
- VisionWave reported a significant net loss of $19.8 million for the six months ending March 31, 2026, reflecting a steep increase compared to a loss of $232,565 for the same period last year, with no revenue generated.…
- 10-Q · February 17, 2026
- VisionWave reported no revenue and a large quarter-on-quarter deterioration: net loss of $6,935,915 (EPS $(0.46)) for the three months ended December 31, 2025 compared with a net loss of $203,724 (EPS $(0.02)) in the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing VWAV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever